Utah § 58-37-109 - Listed controlled substances.

Effective 5/6/2026
58-37-109.  Listed controlled substances.
     The following substances, their analogs, homologs, and synthetic equivalents, are listed controlled substances:

(1)

AB-001;

(2)	AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;

(3)	AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide;

(4)	AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);

(5)	ADB-CHMINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)indazole-3-carboxamide);

(6)	ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1- (4-fluorobenzyl)-1H-indazole-3-caboxamide);

(7)

AKB48;

(8)	alpha-Pyrrolidinohexanophenone (alpha-PHP) (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one);

(9)	alpha-Pyrrolidinovalerophenone (alpha-PVP);

(10)	AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone);

(11)

AM-1248;

(12)	AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole);

(13)

AM-2233;

(14)

AM-679;

(15)

A796,260;

(16)

Butylone;

(17)	CP 47,497 and its C6, C8, and C9 homologs (2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol);

(18)	Diisopropyltryptamine (DiPT);

(19)

Ethylone;

(20)	Ethylphenidate;

(21)	Fluoroisocathinone;

(22)	Fluoromethamphetamine;

(23)	Fluoromethcathinone;

(24)	FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate;

(25)	HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(26)	HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2- methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(27)	JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;

(28)	JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole};

(29)	JWH-019; 1-hexyl-3-(1-naphthoyl)indole;

(30)	JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole};

(31)	JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;

(32)	JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);

(33)	JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;

(34)	JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;

(35)	JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;

(36)	JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;

(37)	JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;

(38)	JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;

(39)

MAM-2201;

(40)	MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;

(41)	Methoxetamine;

(42)	Naphyrone;

(43)	PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(44)	Pentedrone;

(45)	Pentylone;

(46)	RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;

(47)	RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18};

(48)

STS-135;

(49)

UR-144;

(50)	UR-144 N-(5-chloropentyl) analog;

(51)

XLR11;

(52)

2C-C;

(53)

2C-D;

(54)

2C-E;

(55)

2C-H;

(56)

2C-I;

(57)

2C-N;

(58)

2C-P;

(59)

2C-T-2;

(60)

2C-T-4;

(61)

2NE1;

(62)	25I-NBOMe;

(63)	2,5-Dimethoxy-4-chloroamphetamine (DOC);

(64)	4-Fluoro MDMB-BUTINACA (Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate);

(65)	4-methylmethcathinone {also known as mephedrone};

(66)	3,4-methylenedioxypyrovalerone {also known as MDPV};

(67)	3,4-Methylenedioxymethcathinone {also known as methylone};

(68)	4-methoxymethcathinone;

(69)	4-Methyl-alpha-pyrrolidinopropiophenone;

(70)	4-Methylethcathinone;

(71)	5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;

(72)	5-Fluoro ADB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methyl-valinate);

(73)	5-Fluoro AMB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate);

(74)	5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(75)	5-Iodo-2-aminoindane (5-IAI);

(76)	5-MeO-DALT;

(77)	25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;

(78)	25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and

(79)	25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.

Renumbered and Amended by Chapter 362, 2026 General Session